HIV-associated tuberculosis in the era of HAART

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 11, 2000, Pages 993-994

  Pozniak, A ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; ZIDOVUDINE;

CHEMOPROPHYLAXIS; DEVELOPING COUNTRY; DISEASE ASSOCIATION; EDITORIAL; HEALTH PROGRAM; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; LUNG TUBERCULOSIS; PRIORITY JOURNAL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DEVELOPING COUNTRIES; HUMANS; TUBERCULOSIS;

EID: 0033767599     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (11)

1. Isoniazid prophylaxis for tuberculosis in HIV infection: A meta-analysis of randomized controlled trials
2. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: An operational assessment at a voluntary counselling and testing centre
3. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia
4. Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: Results of a randomized controlled trial
5. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration
6. Declining morbidity and mortality among patients with advanced immunodeficiency virus infection
7. Changing patterns of mortality across Europe in patients infected with HIV-1. Euro-SIDA Study Group
8. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: Prospective multicentre study. Swiss HIV Cohort Study
9. HIV-associated tuberculosis in the era of highly active antiretroviral therapy
10. Delta: A randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HW-infected individuals